A Strife

3.2k total citations
59 papers, 2.7k citations indexed

About

A Strife is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, A Strife has authored 59 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Hematology, 24 papers in Genetics and 18 papers in Molecular Biology. Recurrent topics in A Strife's work include Chronic Myeloid Leukemia Treatments (25 papers), Chronic Lymphocytic Leukemia Research (20 papers) and Acute Myeloid Leukemia Research (18 papers). A Strife is often cited by papers focused on Chronic Myeloid Leukemia Treatments (25 papers), Chronic Lymphocytic Leukemia Research (20 papers) and Acute Myeloid Leukemia Research (18 papers). A Strife collaborates with scholars based in United States, Switzerland and Slovakia. A Strife's co-authors include Bayard D. Clarkson, David Wisniewski, C Lambek, B Clarkson, Nick Carpino, Jerrold Fried, Ryûji Kobayashi, Daniel R. Marshak, Bruce Stillman and Étienne de Harven and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

A Strife

59 papers receiving 2.6k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
A Strife 1.3k 1.2k 780 544 501 59 2.7k
Keiko Okuda 1.2k 0.9× 949 0.8× 747 1.0× 651 1.2× 717 1.4× 67 2.6k
SJ Sharkis 1.2k 0.9× 779 0.7× 607 0.8× 379 0.7× 352 0.7× 36 2.1k
Thomas Kindler 1.7k 1.3× 1.5k 1.3× 768 1.0× 615 1.1× 342 0.7× 78 3.0k
Masayuki Towatari 1.6k 1.2× 1.7k 1.5× 595 0.8× 570 1.0× 433 0.9× 40 2.9k
Claudia S. Huettner 1.5k 1.1× 1.5k 1.3× 689 0.9× 714 1.3× 933 1.9× 44 3.3k
Harald Herrmann 1.4k 1.1× 2.1k 1.8× 533 0.7× 647 1.2× 610 1.2× 72 3.3k
Tetsuzo Tauchi 1.5k 1.1× 1.6k 1.4× 911 1.2× 621 1.1× 442 0.9× 146 3.1k
Sabine Cerny‐Reiterer 849 0.6× 808 0.7× 576 0.7× 453 0.8× 692 1.4× 65 2.2k
Carol A. Westbrook 677 0.5× 1.1k 1.0× 434 0.6× 509 0.9× 329 0.7× 75 2.3k
María D. Odero 1.3k 0.9× 1.8k 1.6× 603 0.8× 476 0.9× 250 0.5× 88 2.9k

Countries citing papers authored by A Strife

Since Specialization
Citations

This map shows the geographic impact of A Strife's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Strife with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Strife more than expected).

Fields of papers citing papers by A Strife

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Strife. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Strife. The network helps show where A Strife may publish in the future.

Co-authorship network of co-authors of A Strife

This figure shows the co-authorship network connecting the top 25 collaborators of A Strife. A scholar is included among the top collaborators of A Strife based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Strife. A Strife is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clarkson, B, et al.. (2003). Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies. Leukemia. 17(7). 1211–1262. 83 indexed citations
2.
Strife, A, David Wisniewski, C Lambek, et al.. (2003). Direct evidence that Bcr-Abl tyrosine kinase activity disrupts normal synergistic interactions between Kit ligand and cytokines in primary primitive progenitor cells.. PubMed. 1(3). 176–85. 12 indexed citations
3.
Liang, Xiquan, et al.. (2002). Phosphatidylinositol 3-Kinase and Src Family Kinases Are Required for Phosphorylation and Membrane Recruitment of Dok-1 in c-Kit Signaling. Journal of Biological Chemistry. 277(16). 13732–13738. 45 indexed citations
4.
Wisniewski, David, et al.. (2000). The phosphatidylinositol polyphosphate 5-phosphatase SHIP1 associates with the Dok1 phosphoprotein in Bcr-Abl transformed cells. Cellular Signalling. 12(5). 317–326. 23 indexed citations
5.
Berman, Ellin, Suresh C. Jhanwar, Mary L. McBride, et al.. (2000). Characterization of two novel sublines established from a human megakaryoblastic leukemia cell line transfected with p210BCR-ABL. Leukemia Research. 24(4). 289–297. 8 indexed citations
7.
Cristofano, Antonio Di, Nick Carpino, Ryûji Kobayashi, et al.. (1998). Molecular Cloning and Characterization of p56 Defines a New Family of RasGAP-binding Proteins. Journal of Biological Chemistry. 273(9). 4827–4830. 114 indexed citations
8.
Strife, A, et al.. (1997). New understanding of the pathogenesis of CML: a prototype of early neoplasia. Leukemia. 11(9). 1404–1428. 59 indexed citations
9.
Carpino, Nick, David Wisniewski, A Strife, et al.. (1997). p62 : A Constitutively Tyrosine-Phosphorylated, GAP-Associated Protein in Chronic Myelogenous Leukemia Progenitor Cells. Cell. 88(2). 197–204. 334 indexed citations
10.
Wisniewski, David, A Strife, & B Clarkson. (1996). c-kit ligand stimulates tyrosine phosphorylation of the c-Cbl protein in human hematopoietic cells.. PubMed. 10(9). 1436–42. 32 indexed citations
11.
12.
Clarkson, B, A Strife, Alexendar R. Perez, C Lambek, & David Wisniewski. (1993). Integration of Molecular and Biological Abnormalities in Quest for Selective Treatment of Chronic Myelogenous Leukemia (CML). Leukemia & lymphoma. 11(sup2). 81–100. 6 indexed citations
13.
Clarkson, Bayard & A Strife. (1993). Linkage of proliferative and maturational abnormalities in chronic myelogenous leukemia and relevance to treatment.. PubMed. 7(11). 1683–721. 56 indexed citations
14.
Wisniewski, David, A Strife, Alexendar R. Perez, et al.. (1992). Constitutive expression of p53 protein in enriched normal human marrow blast cell populations [see comments]. Blood. 79(8). 1982–1986. 29 indexed citations
15.
Lemoli, Roberto M., Agostino Tafuri, A Strife, et al.. (1992). Proliferation of human hematopoietic progenitors in long-term bone marrow cultures in gas-permeable plastic bags is enhanced by colony-stimulating factors.. Experimental Hematology. 20(5). 569–75. 14 indexed citations
16.
Wisniewski, David, A Strife, & Bayard D. Clarkson. (1991). Co-detection of chimeric bcr/abl (target) and β-actin (control) messenger RNA in individual CFU-GM colonies derived from CML patients using the polymerase chain reaction. Leukemia Research. 15(9). 867–874. 7 indexed citations
17.
Nocka, K, et al.. (1991). Monoclonal antibody YB5.B8 identifies the human c-kit protein product. Blood. 77(9). 1876–1883. 139 indexed citations
18.
Strife, A & Bayard D. Clarkson. (1988). Biology of chronic myelogenous leukemia: is discordant maturation the primary defect?. PubMed. 25(1). 1–19. 87 indexed citations
19.
Konopka, James B., Susan Spierre Clark, J McLaughlin, et al.. (1986). Variable expression of the translocated c-abl oncogene in Philadelphia-chromosome-positive B-lymphoid cell lines from chronic myelogenous leukemia patients.. Proceedings of the National Academy of Sciences. 83(11). 4049–4052. 30 indexed citations
20.
Yataganas, Xenophon, et al.. (1975). Evaluation of a Feulgen- type reaction in suspension using flow microfluorimetry and a cell separation technique.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 19(1). 71–8. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026